CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lajous, M.
Right arrow Articles by Romieu, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lajous, M.
Right arrow Articles by Romieu, I.
Cancer Epidemiology Biomarkers & Prevention Vol. 15, 443-448, March 2006
© 2006 American Association for Cancer Research

Folate, Vitamin B6, and Vitamin B12 Intake and the Risk of Breast Cancer Among Mexican Women

Martin Lajous1, Eduardo Lazcano-Ponce1, Mauricio Hernandez-Avila1, Walter Willett2 and Isabelle Romieu1

1 Center for Population Health Research, Instituto Nacional de Salud Publica, Cuernavaca, Mexico and 2 Departments of Nutrition and Epidemiology, Harvard School of Public Health; The Channing Laboratory; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

Requests for reprints: Isabelle Romieu, Instituto Nacional de Salud Publica, Av. Universidad 655, Col. Santa Maria Ahuacatitlan, Cuernavaca, Morelos 62508, Mexico. Phone: 52-777-101-2935; Fax: 52-777-311-1148. E-mail: iromieu{at}correo.insp.mx

Background: High intake of folate, vitamin B6, and vitamin B12 have been hypothesized to lower the risk for breast cancer. We conducted a population-based case-control study to evaluate the risk for breast cancer among Mexican women with relatively low vitamin intakes.

Methods: We included 475 women (median age, 53 years; range, 23-87 years) diagnosed with incident breast cancer through six hospitals in Mexico City and interviewed them to obtain data on breast cancer risk factors and their usual diet using a food frequency questionnaire. We selected 1,391 (median age, 49 years; range, 18-82 years) controls from the Mexico City population using a national sampling frame.

Results: Compared with women in the lowest quartile, the odds ratio for breast cancer for women in the highest quartile of folate intake was 0.64 [95% confidence intervals (CI), 0.45-0.90; P, test for trend = 0.009] and 0.32 (95% CI, 0.22-0.49; P, test for trend < 0.0001) for vitamin B12 intake. Among postmenopausal women, intakes of folate and vitamin B12 were associated with a lower risk of breast cancer and those associations were stronger than among premenopausal women. The inverse association of folate and breast cancer was stronger among women who consumed a high level of vitamin B12 as compared with women consuming diets low in vitamin B12. No association was observed for vitamin B6 intake.

Conclusions: In this population, high intakes of folate and vitamin B12 were independently associated with decreased breast cancer risk, particularly among postmenopausal women. (Cancer Epidemiol Biomarkers Prev 2006;15(3):443–8)




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
A D. Smith, Y.-I. Kim, and H. Refsum
Is folic acid good for everyone?
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 517 - 533.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. Lin, I-M. Lee, N. R Cook, J. Selhub, J. E Manson, J. E Buring, and S. M Zhang
Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 734 - 743.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. Cho, M. Holmes, S. E. Hankinson, and W. C. Willett
Nutrients Involved in One-Carbon Metabolism and Risk of Breast Cancer among Premenopausal Women
Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2787 - 2790.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
U. Ericson, E. Sonestedt, B. Gullberg, H. Olsson, and E. Wirfalt
High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmo Diet and Cancer cohort
Am. J. Clinical Nutrition, August 1, 2007; 86(2): 434 - 443.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
V. L. Stevens, M. L. McCullough, A. L. Pavluck, J. T. Talbot, H. S. Feigelson, M. J. Thun, and E. E. Calle
Association of Polymorphisms in One-Carbon Metabolism Genes and Postmenopausal Breast Cancer Incidence
Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1140 - 1147.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. C. Larsson, E. Giovannucci, and A. Wolk
Folate and Risk of Breast Cancer: A Meta-analysis
J Natl Cancer Inst, January 3, 2007; 99(1): 64 - 76.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. J. Lewis, R. M. Harbord, R. Harris, and G. D. Smith
Meta-analyses of Observational and Genetic Association Studies of Folate Intakes or Levels and Breast Cancer Risk.
J Natl Cancer Inst, November 15, 2006; 98(22): 1607 - 1622.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2006 by the American Association for Cancer Research.